South Korea based Samsung Biologics' partnership with Eli Lilly and Company is expected to greatly accelerate the global...
Croda International Plc (“Croda” or “the Group”), the speciality chemical company that uses smar...
GenScript Biotech Corporation's cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit has receive...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and GL Rapha, one of the leading South ...
QIAGEN has recently started commercialization of a portable digital test in the United States that can be used by labora...
Arcturus Therapeutics Holdings Inc., based in the US, has announced positive interim clinical study results from its ong...
GenScript USA Inc, the world's leading research reagent provider, has announced that the US Food and Drug Admi...
Researchers from the Kirby Institute at UNSW Sydney, Australia together with colleagues in the United States and Europ...
Korea's Celltrion Group on 5 Nov 2020 announced results from the ongoing Phase I clinical trial of CT-P59, an anti-COVID...
Information will be updated weekly. If you notice an issue with this data or wish to submit an update, please email BioS...
In early August, India announced the National Digital Health Mission (NDHM), which indicated their commitment to rapidly...
Recently, protective masks by China-based Daddybaby were certified by the British Standards Institution (BSI) and also p...
Two more COVID-19 vaccines have been secured for the Australian population under new agreements, bringing the Australian...
SenseTime, the world-leading artificial intelligence (AI) company, on 4 Nov 2020 announced its AI-empowered software sol...
Exploring the unique set of scenarios put into motion by the COVID-19 pandemic, researchers from Japan's Kyushu Universi...
Automating the collection and presentation of healthcare data is crucial in the fight against COVID-19 – it ...
A virtual workshop on combating illegal activity related to COVID-19 was held by Taiwan, Australia, Japan and the U.S....
US based Humanigen, Inc., a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-...
